Companion Animal Diagnostics Market to Hit US$ 14.7 Billion by 2034

Trishita Deb
Trishita Deb

Updated · May 7, 2025

SHARE:

Market.us Media, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Learn more.
close
Advertiser Disclosure

At Market.us Media, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Our data is available to the public free of charge, and we encourage you to use it to inform your personal or business decisions. If you choose to republish our data on your own website, we simply ask that you provide a proper citation or link back to the respective page on Market.us Media. We appreciate your support and look forward to continuing to provide valuable insights for our audience.

Introduction

The Global Companion Animal Diagnostics Market is projected to grow from USD 6 billion in 2024 to USD 14.7 billion by 2034, expanding at a compound annual growth rate (CAGR) of 9.4%. This growth is being driven by public health priorities, advancements in veterinary technologies, and the evolving role of pets in households. Increasing pet ownership and rising concerns about animal health are boosting demand for diagnostic services that are fast, accurate, and accessible. Veterinary clinics and laboratories are increasingly adopting modern diagnostic tools, aligning with public health initiatives and the evolving expectations of pet owners.

One of the key drivers of this market is the One Health approach, promoted by the World Health Organization (WHO). This approach links human, animal, and environmental health. It emphasizes the importance of early disease detection in animals, especially zoonotic diseases, which can spread to humans. Companion animals play a critical role in this system. As a result, public health agencies are investing in diagnostic systems that enhance surveillance. These efforts are strengthening diagnostic capacity worldwide and contributing to steady market growth.

Government organizations have also supported veterinary diagnostics infrastructure. The U.S. Food and Drug Administration (FDA) has developed networks like the Veterinary Laboratory Investigation and Response Network (Vet-LIRN). These networks connect veterinary laboratories across the country to monitor and investigate disease outbreaks. They provide crucial support for rapid disease detection and promote standardized diagnostic practices. As a result, the infrastructure needed to support animal health is improving, creating a foundation for increased adoption of diagnostics technologies.

Technological innovations are reshaping diagnostic practices in veterinary medicine. Advanced tools such as molecular diagnostics, immunoassays, and point-of-care testing are being widely adopted. These technologies provide rapid and reliable results, allowing veterinarians to make quicker treatment decisions. The availability of such diagnostics supports better disease management in companion animals. It also aligns with public health strategies aimed at preventing the spread of infectious diseases. This is contributing to stronger demand across clinics and animal health centers.

Furthermore, demographic changes are influencing diagnostic demand. As pets live longer due to improved care and nutrition, chronic conditions such as diabetes, arthritis, and kidney disease are becoming more common. This shift is increasing the need for routine testing and long-term monitoring. Pet owners are also becoming more aware of preventive care, leading to greater demand for early detection and regular diagnostics. These factors are expected to play a central role in sustaining the long-term growth of the companion animal diagnostics market.

Companion Animal Diagnostics Market Size

Key Takeaways

  • In 2024, the global Companion Animal Diagnostics Market generated a revenue of approximately US$ 5.99 billion, projected to reach US$ 13.42 billion by 2034.
  • The market is expected to expand at a compound annual growth rate (CAGR) of 9.4% throughout the forecast period, indicating steady industry progress.
  • Among animal types, dogs dominated the market in 2024, contributing the largest share of 42.7% to the overall revenue.
  • In terms of technology, the Clinical Biochemistry segment emerged as the top contributor, accounting for 25.2% of the total market share.
  • Based on application, Clinical Pathology led with a significant 30.1% market share, highlighting its critical role in veterinary diagnostics.
  • Regionally, North America held the dominant position by capturing 46.10% of the total market, driven by advanced veterinary infrastructure and pet ownership rates.

Regional Analysis

North America dominates the global companion animal diagnostics market due to a combination of factors, including high pet ownership and a mature veterinary healthcare infrastructure. According to the American Pet Products Association (APPA), over 67% of U.S. households own pets. This rising trend in pet adoption has created a strong demand for veterinary diagnostic services. Pet owners are increasingly willing to invest in early disease detection and preventive care. These preferences have significantly contributed to the expansion of the diagnostic services market across the region.

The presence of a well-developed healthcare system has further fueled market growth. Veterinary clinics and hospitals in North America are equipped with advanced diagnostic tools and technologies. These include PCR-based testing, digital imaging, and rapid diagnostic kits. Moreover, access to high-quality veterinary care is supported by well-trained professionals and standardized protocols. This enables early disease diagnosis and effective treatment. The region’s healthcare ecosystem supports timely and precise diagnostics, which is crucial in managing pet health efficiently.

North America also benefits from robust research and development (R&D) initiatives. Many key players in the animal health industry are headquartered in the United States and Canada. These companies invest heavily in innovation and product development. AI-powered diagnostic solutions and point-of-care testing devices have been introduced to meet growing clinical demands. The continuous advancement of veterinary diagnostic technologies strengthens the region’s leadership in the global market.

Telemedicine adoption, which grew significantly during the COVID-19 pandemic, has expanded access to veterinary services. Pet owners now benefit from virtual consultations and remote diagnostics. This development has improved pet healthcare delivery and supported the market’s growth. Additionally, the increasing humanization of pets has driven higher spending on health services. Owners are more focused on quality care and regular screening. With a strong infrastructure and growing consumer awareness, North America is likely to maintain its dominant market position.

Emerging Trends

  • Advancements in Diagnostic Technologies: Modern technologies are changing how diseases are detected in pets. Tools like point-of-care (POC) testing and artificial intelligence (AI) are helping vets get faster and more accurate results. POC tests provide immediate outcomes during a clinic visit, enabling quick treatment decisions. AI-based diagnostics are used to analyze test results with greater precision. Molecular diagnostic methods are also becoming common, especially for detecting infections and genetic conditions. These innovations help veterinarians make better clinical decisions and improve health outcomes for pets. The focus is now shifting toward technologies that combine speed, accuracy, and ease of use in daily veterinary practice.
  • Rise in Preventive Healthcare Initiatives: Veterinarians are promoting routine health checks to detect diseases early. Regular screenings such as wellness panels, blood tests, and fecal exams are gaining popularity. These tests help identify issues before they become serious. Early diagnosis can lead to more effective and less expensive treatments. This shift toward preventive care is supported by pet owners who want to keep their animals healthy for longer. It also reduces the burden on emergency care systems. As awareness grows, more clinics are including preventive diagnostics in their standard services, improving the overall quality of pet care.
  • Increasing Pet Ownership and Humanization of Pets: More people around the world are adopting pets, and they are treating them like family. This emotional connection is driving the demand for high-quality veterinary care, including diagnostics. Pet owners now seek advanced testing for early disease detection and overall health monitoring. They are willing to invest in specialized services that were once limited to human healthcare. This trend has also influenced product development, leading to pet-specific diagnostic tools and technologies. The growing number of pets and their elevated status in households are major factors boosting the companion animal diagnostics market.
  • Expansion of Veterinary Infrastructure and Services: Veterinary care is improving across the globe. New clinics with advanced equipment are opening in both urban and rural areas. These facilities offer services such as imaging, lab testing, and telemedicine. Trained veterinary professionals are also becoming more available. As access improves, more pet owners are seeking diagnostic services. This expansion is helping to meet the rising demand for early and accurate diagnosis. Governments and private investors are also supporting this growth by funding veterinary education and infrastructure. As a result, better diagnostic services are now reaching more animals, even in underserved regions.
  • Market Shift Toward Eco-Friendly Diagnostic Solutions: Sustainability is becoming a key goal in animal healthcare. Veterinary labs and diagnostic companies are exploring greener solutions. These include biodegradable test kits and energy-saving lab equipment. Reducing plastic waste and harmful chemicals is a growing concern. Many companies now use recyclable materials and safer reagents in their test systems. This shift is supported by regulations and by consumers who care about the environment. Eco-friendly innovations are not only good for the planet but also help clinics reduce operational costs. The focus on sustainability is likely to shape future developments in veterinary diagnostics.

Use Cases

  • Early Disease Detection: Early diagnosis helps catch diseases in pets before symptoms appear. Routine blood tests, for example, can detect early signs of diabetes or kidney issues. This gives veterinarians and pet owners a chance to begin treatment sooner. Early intervention improves the pet’s quality of life and helps avoid costly emergency care. Many clinics now recommend annual wellness checks, which often include lab tests for this reason. These tests are simple, fast, and highly effective in supporting preventive care.
  • Monitoring Chronic Conditions: Pets with long-term illnesses, like heart disease or arthritis, need constant monitoring. Regular diagnostics help track how the disease is progressing. Blood work, X-rays, and ultrasound scans are common tools used. These tests allow veterinarians to adjust medications or treatments when necessary. Monitoring improves the chances of managing the condition successfully. It also helps pet owners understand the health changes in their pets. This kind of care is becoming standard in modern veterinary practice.
  • In-House Diagnostic Testing: Many veterinary clinics now use in-house diagnostic equipment. These tools allow tests to be done during a regular visit. It removes the need to send samples to external labs. As a result, veterinarians can make quick decisions about treatment. In-house testing is widely used for blood analysis, urinalysis, and imaging. It supports faster diagnosis and better emergency care. This trend reflects a shift toward more immediate and proactive pet healthcare.
  • Detection of Zoonotic Diseases: Zoonotic diseases can pass from animals to humans. Accurate diagnostics are important to detect these infections early. Diseases like rabies, leptospirosis, and toxoplasmosis require fast testing and reporting. Diagnostic tools help protect both pets and humans. These tools are essential for public health monitoring. Governments and health agencies often require testing in certain cases. This ensures outbreaks can be controlled quickly. Preventing zoonotic transmission is a major goal of veterinary diagnostics today.
  • Genetic Testing for Breed-Specific Conditions: Certain breeds are at higher risk for specific diseases. Genetic testing can identify these risks early. For example, large dog breeds may have a higher risk of hip dysplasia. DNA-based tests can detect inherited conditions even before symptoms appear. Knowing this information helps owners take preventive steps. It also helps veterinarians make tailored health plans for each pet. Genetic diagnostics are now more available and affordable. This use case is gaining popularity among breeders and pet owners.

Conclusion

The companion animal diagnostics market is growing steadily, supported by better technology, rising pet ownership, and stronger public health systems. Pet owners are now more focused on early detection and preventive care, leading to increased use of diagnostic tools. Advances such as in-house testing and AI-based solutions are making diagnostics faster and more reliable. Veterinary clinics are expanding their services, and governments are supporting improved diagnostic infrastructure. The human-animal bond is also strengthening demand, with pets being treated more like family members. These changes are creating a strong foundation for long-term growth. The market is expected to continue expanding as awareness, access, and innovation improve across global veterinary healthcare systems.

Discuss your needs with our analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

SHARE:
Trishita Deb

Trishita Deb

Trishita has more than 8+ years of experience in market research and consulting industry. She has worked in various domains including healthcare, consumer goods, and materials. Her expertise lies majorly in healthcare and has worked on more than 400 healthcare reports throughout her career.

Latest from the featured industries
Request a Sample Report
We'll get back to you as quickly as possible